{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:12:48Z","timestamp":1793326368743,"version":"4.5.0"},"reference-count":178,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Psoriasis is a chronic, relapsing skin disease driven by failed immune tolerance toward self-antigens and sustained IL-23\/IL-17 signaling. Systemic drugs and biologics control disease in many patients, yet they do not restore lasting tolerance, and most patients relapse after treatment withdrawal. Tolerogenic vaccines aim to re-educate the cutaneous immune system: when administered under non-inflammatory conditions, they push antigen-presenting cells toward tolerogenic dendritic cells (tDCs) and regulatory T cells (Tregs) instead of pathogenic effectors. Because the hyperkeratotic stratum corneum of psoriatic plaques blocks macromolecular vaccines, microneedle (MN) arrays can deposit nanocarriers directly into the dermal-epidermal junction. The narrative review asks whether MN-delivered tolerogenic nanovaccines can advance psoriasis therapy beyond broad immunosuppression. We first define tolerogenic vaccination and explicitly distinguish antigen-specific tolerogenic vaccines, antigen-independent immune-reprogramming nanocarriers, and conventional local drug delivery, then survey MN engineering and nanocarrier architectures, the immunomodulatory pathways involved, and translational barriers spanning manufacturing, safety, and regulation. Because most evidence is preclinical, the level of evidence is reported for each platform, and the unresolved autoantigen problem, the limitations of imiquimod-based models, and the need for human-relevant validation are emphasized.<\/jats:p>","DOI":"10.3390\/vaccines14090784","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:00:04Z","timestamp":1788861604000},"page":"784","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Can Microneedle-Nanocarrier Platforms Deliver True Tolerogenic Immunotherapy for Psoriasis?"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0466-1695","authenticated-orcid":false,"given":"Mingpeng","family":"Feng","sequence":"first","affiliation":[{"name":"Medicine & Technology College, Zunyi Medical University, Zunyi 563000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0451-591X","authenticated-orcid":false,"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[{"name":"USDA\/ARS Children\u2019s Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Petit, R.G., Cano, A., Ortiz, A., Espina, M., Prat, J., Mu\u00f1oz, M., Severino, P., Souto, E.B., Garc\u00eda, M.L., and Pujol, M. (2021). Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094983"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Shokoufa, P., and Aghaei, M. (2025). Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis: Molecular Pathogenesis of Psoriasis. Galen Med. J., 14.","DOI":"10.31661\/gmj.vi.3854"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1007\/s00210-025-03804-w","article-title":"A complete sojourn on nanotechnological advancements and nanocarrier applications in psoriasis management","volume":"398","author":"Thakur","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1021\/acs.molpharmaceut.3c01223","article-title":"Calcipotriol Nanosuspension-Loaded Trilayer Dissolving Microneedle Patches for the Treatment of Psoriasis: In Vitro Delivery and In Vivo Antipsoriatic Activity Studies","volume":"21","author":"Dai","year":"2024","journal-title":"Mol. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2147\/JIR.S506103","article-title":"Psoriasis: Unraveling Disease Mechanisms and Advancing Pharmacological and Nanotechnological Treatments","volume":"18","author":"Miao","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Singh, H., Jha, H., and Taliyan, R. (2026). Regulatory roles of microRNAs in epigenetic and immune gene networks in psoriasis. Gene, 990.","DOI":"10.1016\/j.gene.2026.150081"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Silvestrini, A.V.P., da Silva, U.J., Morais, M.F., Depieri, L.V., and Bentley, M. (2026). Integrating clinical challenges and nanotechnological based approaches for psoriasis therapy. Biomater. Adv., 180.","DOI":"10.1016\/j.bioadv.2025.214625"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Shen, Q., Liu, R., Tan, S., Xu, X., Fang, J., and Li, R. (2022). Advances in pathogenesis and nanoparticles (NPs)-mediated treatment of psoriasis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1089262"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhou, H., Shi, L., Ren, Y., Tan, X., Liu, W., and Liu, Z. (2020). Applications of Human Skin Microbiota in the Cutaneous Disorders for Ecology-Based Therapy. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.570261"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Xu, L., Xiao, Y., Jiang, Y., Deng, J., Xie, W., Luo, Z., Wang, Q., Zeng, Z., and Liu, J. (2026). The dual role of CCL20 in inflammatory disease: Maintenance of host defense and immunopathological balance. Pathol. Res. Pract., 286.","DOI":"10.1016\/j.prp.2026.156586"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.2147\/JIR.S373150","article-title":"Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model","volume":"15","author":"Capriotti","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2023.10.035","article-title":"Disease-specific corona mediated co-delivery of MTX and siRNA-TNF\u03b1 by a polypeptide nanoplatform with antigen-scavenging functions in psoriasis","volume":"364","author":"Xin","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tu, B., Fang, W., Liu, L., Sun, Y., Hu, M., Asrorov, A., Wang, Z., Liu, E., Huang, Y., and Liu, Z. (2026). Microneedle-based delivery of cell membrane vesicles as IL-17RA decoys for Psoriasis treatment. J. Nanobiotechnol., 24.","DOI":"10.1186\/s12951-026-04265-w"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"27884","DOI":"10.1021\/jacs.6c09469","article-title":"Deep-Penetrating Transdermal Lipopeptide Liposomes for Sustained IL-17 Inhibition and Prevention of Psoriatic Recurrence","volume":"148","author":"Cong","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Khorrami, R., Shobeiri, S.S., Emami, Z., Haghnavaz, N., Rezaee, M.A., Pordel, S., Moghadam, M., and Sankian, M. (2025). Conjugation of Gold Nanoparticles to the Anti-IL17A Aptamer Improves Anti-Inflammatory Effects of the Aptamer in the Experimental Imiquimod-Induced Psoriasis. Int. J. Inflam., 2025.","DOI":"10.1155\/ijin\/9916368"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Yao, L., Tian, F., Meng, Q., Guo, L., Ma, Z., Hu, T., Liang, Q., and Li, Z. (2024). Reactive oxygen species-responsive supramolecular deucravacitinib self-assembly polymer micelles alleviate psoriatic skin inflammation by reducing mitochondrial oxidative stress. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1407782"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/cbin.11841","article-title":"siRNA-based nanotherapeutics as emerging modalities for immune-mediated diseases: A preliminary review","volume":"46","author":"Sargazi","year":"2022","journal-title":"Cell Biol. Int."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Cai, X., Zhang, L., Fei, W., Qin, D., Zhang, X., Zhu, J., Zheng, C., and Yao, Y. (2026). Advances in nanotechnology for the diagnosis and management of autoimmune diseases. Asian J. Pharm. Sci., 21.","DOI":"10.1016\/j.ajps.2026.101144"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Moorman, C.D., Sohn, S.J., and Phee, H. (2021). Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.657768"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Deng, D., Chen, R., Lin, S., Tao, Y., Pei, G., Cheng, B., Zhao, M., Cheng, H., Yan, J., and Wang, X. (2025). Fire cupping inspired negative-pressure microneedle syringes loaded with herb berberine-based nano composite for psoriasis therapy. Biomater. Adv., 173.","DOI":"10.1016\/j.bioadv.2025.214259"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"18058","DOI":"10.1021\/acsnano.6c01427","article-title":"Keratinocyte-Derived Apoptotic Nanovehicles Reprogram Cutaneous Dendritic Cells to Ameliorate Psoriasis","volume":"20","author":"Ma","year":"2026","journal-title":"ACS Nano"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.apsb.2021.07.019","article-title":"Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment","volume":"12","author":"Xi","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zhang, W., Chen, Y., Zhao, Z., Zheng, H., Wang, S., Liao, Z., Sheng, T., Zhao, S., Hou, W., and Yu, X. (2023). Adoptive T(reg) therapy with metabolic intervention via perforated microneedles ameliorates psoriasis syndrome. Sci. Adv., 9.","DOI":"10.1126\/sciadv.adg6007"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Parashar, A.K., Saini, K., Sethi, V.A., and Gupta, C. (2025). A Review on Current Challenges and Emerging Therapies in Psoriasis Management. Rev. Recent Clin. Trials, 21.","DOI":"10.2174\/0115748871393960250912053926"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Zhou, Y., Ma, X., Duan, Z., Xu, H., Li, Y., Kong, Y., Yang, L., and Xin, X. (2025). Topical Therapy in Psoriasis: Clinical Benefits, Advances in Novel Drug Delivery Strategies, and Gene Therapy Regimen. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17030283"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Huang, L., Luo, Y., Kuai, L., Zhang, X., Zhang, Y., Yang, Z., Fei, X., Sun, J., Luo, Y., and Zhao, Y. (2025). An approach for psoriasis of microneedle patch simultaneously targeting multiple inflammatory cytokines and relapse related T cells. Biomaterials, 318.","DOI":"10.1016\/j.biomaterials.2025.123120"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ma, X., Cong, R., Cui, X., Tang, Y., Ren, J., Hou, J., Liu, B., Zhao, J., Li, P., and Li, L. (2025). Dendritic lipopeptide-based transdermal siRNA delivery systems for effective non-invasive therapy in psoriasis. J. Control. Release, 381.","DOI":"10.1016\/j.jconrel.2025.113581"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Shen, S., Shen, W., Wang, L., Sun, B., Zhang, Y., Zhang, Y., Jia, R., Wu, Y., Chen, X., and Cao, K. (2025). Berberine hydrochloride-loaded liposomes-in-hydrogel microneedles achieve the efficient treatment for psoriasis. Mater. Today Bio, 32.","DOI":"10.1016\/j.mtbio.2025.101795"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zhao, Z., Xu, L., Liu, Y., Wang, X., Hui, Y., Fan, Y., Shi, Y., and Zhao, C.X. (2026). Topical delivery of high-drug-loading nanoparticle gels for psoriasis treatment. J. Nanobiotechnol., 24.","DOI":"10.1186\/s12951-026-04120-y"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Bi, D., Geng, R., Wang, H., Sun, X., Du, H., Tao, J., Liu, Y., and Zhu, J. (2026). Enhanced intracellular delivery of multi-responsive and size-switchable nanoparticles via microneedles for targeted psoriasis therapy. J. Control. Release, 389.","DOI":"10.1016\/j.jconrel.2025.114448"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/acsnano.2c08979","article-title":"Reactive Oxygen Species-Responsive Gel-Based Microneedle Patches for Prolonged and Intelligent Psoriasis Management","volume":"17","author":"Bi","year":"2023","journal-title":"ACS Nano"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Liu, S., Song, S., Zhang, Y., Yan, L., Chen, Y., Li, W., Jalil, B., Wu, C., Fu, Y., and Chen, X. (2025). Delivery of penetration-enhancing antioxidant polyphenol nanoparticles with Codonopsis pilosula polysaccharide microneedles for synergistic treatment of psoriasis. Carbohydr. Polym., 363.","DOI":"10.1016\/j.carbpol.2025.123777"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jian, Y., Ban, M., Yan, Z., Wang, Y., Che, Z., Ren, W., Cao, Y., Wang, Z., and Yuan, Y. (2026). Stimuli-Responsive Nanocarriers for Transdermal siRNA Delivery: Mechanisms, Challenges, and Therapeutic Strategies. Int. J. Nanomed., 21.","DOI":"10.2147\/IJN.S595572"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"P\u00fcnnel, L.C., Palmtag, M., Lunter, D.J., and Perry, J.L. (2024). Development of 3D printed microneedles of varied needle geometries and lengths, designed to improve the dermal delivery of topically applied psoriasis treatments. Eur. J. Pharm. Biopharm., 204.","DOI":"10.1016\/j.ejpb.2024.114523"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Vora, D., Garimella, H.T., German, C.L., and Banga, A.K. (2022). Microneedle and iontophoresis mediated delivery of methotrexate into and across healthy and psoriatic skin. Int. J. Pharm., 618.","DOI":"10.1016\/j.ijpharm.2022.121693"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/17425247.2025.2472968","article-title":"Novel strategies in topical delivery for psoriasis treatment: Nanocarriers and energy-driven approaches","volume":"22","author":"Lin","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Chen, J., Ren, H., Zhou, P., Zheng, S., Du, B., Liu, X., and Xiao, F. (2022). Microneedle-mediated drug delivery for cutaneous diseases. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.1032041"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1039\/D0RA00735H","article-title":"Microneedles: A potential strategy in transdermal delivery and application in the management of psoriasis","volume":"10","author":"Zhao","year":"2020","journal-title":"RSC Adv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejpb.2019.05.001","article-title":"Expanding the applications of microneedles in dermatology","volume":"140","author":"Sabri","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/1346-8138.16732","article-title":"Dissolving microneedles for effective and painless intradermal drug delivery in various skin conditions: A systematic review","volume":"50","author":"Hoeksema","year":"2023","journal-title":"J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kumar, A., Kondaveeti, S.B., Tripathi, A.K., Agrawal, M., Singh, T.G., Kumar, D., and Kumar, M. (2026). Smart Stings of Nature: Harnessing Microneedles Assisted Targeted Phytoconstituent Delivery for Dermatological Disorders. AAPS PharmSciTech, 27.","DOI":"10.1208\/s12249-025-03311-4"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Silva, S., Machado, M., and Costa, E.M. (2026). Polymeric Nanogels for Skin Applications. Gels, 12.","DOI":"10.3390\/gels12050354"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Deng, T., Zhang, Y., Yao, Y., Ye, P., Zhang, D., Cheng, F., Wu, J., Cheng, H., and Lu, J. (2025). Exosome therapeutics: A paradigm shift in skin repair through multidimensional immunomodulation and biomaterial-driven delivery. Biomed. Pharmacother., 193.","DOI":"10.1016\/j.biopha.2025.118830"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Singh, D. (2026). Advances in lipid nanoparticle delivery systems for targeted cytokine immunotherapy in autoimmune disorders. Cytokine, 198.","DOI":"10.1016\/j.cyto.2025.157098"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Moawad, F., Ruel, Y., Pouliot, R., and Brambilla, D. (2026). Microneedle Technology in Psoriasis Management: Mechanistic Insights, Technological Innovation, Clinical Progress, and Challenges. Adv. Healthc. Mater., 15.","DOI":"10.1002\/adhm.202504294"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Liu, S., Deng, T., Cheng, H., Lu, J., and Wu, J. (2025). Advances in Transdermal Drug Delivery Systems and Clinical Applications in Inflammatory Skin Diseases. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17060746"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Uddin, M.J., Baig, M.S., Gholap, A.D., Khan, J.T., Sheikh, I.A., Choonara, Y.E., and Faiyazuddin, M. (2025). Advances in 3D Printed Microneedles as a Prototype for Skin Targeted Therapeutics in Personalized Dermal Pharmaceuticals. AAPS PharmSciTech, 27.","DOI":"10.1208\/s12249-025-03295-1"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kaplan, M., Arslan, F.B., \u00d6zt\u00fcrk, S.C., Ulut\u00fcrk, S., Meri\u00e7\u00f6z, \u00c7.A., Esenda\u011fl\u0131, G., \u00c7al\u0131\u015f, S., and \u00d6zt\u00fcrk, K. (2026). Development and in vitro\/in vivo evaluation of polymeric dissolving microneedle formulation for psoriasis treatment. Eur. J. Pharm. Sci., 218.","DOI":"10.1016\/j.ejps.2026.107429"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Men, Z., Su, T., Tang, Z., Liang, J., and Shen, T. (2022). Tacrolimus nanocrystals microneedle patch for plaque psoriasis. Int. J. Pharm., 627.","DOI":"10.1016\/j.ijpharm.2022.122207"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Shen, S., Zheng, X., Dong, X., Fang, M., Wan, A., Zhu, T., Yang, Q., Xie, J., and Yan, Q. (2024). Methotrexate-loaded hyaluronan-modified liposomes integrated into dissolving microneedles for the treatment of psoriasis. Eur. J. Pharm. Sci., 195.","DOI":"10.1016\/j.ejps.2024.106711"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Tekko, I.A., Permana, A.D., Vora, L., Hatahet, T., McCarthy, H.O., and Donnelly, R.F. (2020). Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis. Eur. J. Pharm. Sci., 152.","DOI":"10.1016\/j.ejps.2020.105469"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.actbio.2015.05.036","article-title":"Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays","volume":"24","author":"Korkmaz","year":"2015","journal-title":"Acta Biomater."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2024.09.032","article-title":"Cyanocobalamin-loaded dissolving microneedles diminish skin inflammation in vivo","volume":"375","author":"Guillot","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1007\/s13346-024-01542-9","article-title":"Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model","volume":"14","author":"Guillot","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"How, K.N., Yap, W.H., Lim, C.L.H., Goh, B.H., and Lai, Z.W. (2020). Hyaluronic Acid-Mediated Drug Delivery System Targeting for Inflammatory Skin Diseases: A Mini Review. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01105"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/thno.29715","article-title":"CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Xia, C., Fu, X., Wang, Q., Chen, X., Chen, J., Kang, Y., and Wang, B. (2024). Anti-ROS and NIR-II-Responsive Hyaluronic Acid Microneedle Loaded With Baicalin Nanoparticles for Treatment of Psoriasis. Macromol. Rapid Commun., 45.","DOI":"10.1002\/marc.202400136"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"15162","DOI":"10.1021\/acsami.3c00058","article-title":"Supramolecular Dissolving Microneedle Patch Loading Hydrophobic Glucocorticoid for Effective Psoriasis Treatment","volume":"15","author":"Wang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Mohite, P., Puri, A., Munde, S., Ade, N., Kumar, A., Jantrawut, P., Singh, S., and Chittasupho, C. (2024). Hydrogel-Forming Microneedles in the Management of Dermal Disorders Through a Non-Invasive Process: A Review. Gels, 10.","DOI":"10.3390\/gels10110719"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Qin, S., Qin, G., Wan, Y., Liao, S., and Ni, X. (2026). ROS-responsive bilayer microneedles loaded with methotrexate and cerium oxide nanoparticles for synergistic treatment of psoriasis. Int. J. Pharm., 690.","DOI":"10.1016\/j.ijpharm.2025.126520"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Wang, C., Zhou, L., Han, Z., He, L., Yuan, J., Zhang, J., Zhu, Q., and Wang, S. (2025). Microneedle system carrying Momordin Ic-loaded ROS-responsive hydrogel ameliorates psoriasis via targeted anti-inflammatory and reactive oxygen species (ROS)-scavenging mechanisms. Int. J. Pharm., 676.","DOI":"10.1016\/j.ijpharm.2025.125530"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2147\/IJN.S394957","article-title":"Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy","volume":"18","author":"Zhou","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Wang, Z.Y., Zhao, Z.Q., Sheng, Y.J., Chen, K.J., Chen, B.Z., Guo, X.D., and Cui, Y. (2024). Dual-Action Psoriasis Therapy: Antiproliferative and Immunomodulatory Effects via Self-Locking Microneedles. Adv. Sci., 11.","DOI":"10.1002\/advs.202409359"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Wang, T., Li, D., Bi, H., Liu, Y., Xu, X., Wang, H., Jin, Q., Chen, S., Lyu, L., and Shi, J. (2026). A bilayered microneedle patch loaded with methotrexate and dexamethasone for transdermal treatment of psoriasis. Sci. Rep., 16.","DOI":"10.1038\/s41598-026-38216-0"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Li, D., Wang, T., Liu, Y., Bi, H., Xu, X., Wang, H., Jin, Q., Chen, S., Lyu, L., and Shi, J. (2026). A Double-Layer Microneedle Patch Containing Methylprednisolone and Upadacitinib-Loaded Mesoporous Silica Nanocomposites for Psoriasis Treatment. Macromol. Biosci., 26.","DOI":"10.1002\/mabi.202500530"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jconrel.2025.01.037","article-title":"Smart core-shell microneedles for psoriasis therapy: In situ self-assembly of calcium ion-coordinated dexamethasone hydrogel","volume":"379","author":"He","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Zheng, B., Li, Q., Fang, L., Cai, X., Liu, Y., Duo, Y., Li, B., Wu, Z., Shen, B., and Bai, Y. (2024). Microorganism microneedle micro-engine depth drug delivery. Nat. Commun., 15.","DOI":"10.1038\/s41467-024-53280-8"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/acsbiomaterials.5c00247","article-title":"Preclinical Assessment of Living Therapeutic Materials: State-of-Art and Challenges","volume":"11","author":"Desai","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Cai, Y., Huang, S., Zhang, Z., Zhang, J., Zhu, X., Chen, X., and Ding, X. (2022). Bioinspired Rotation Microneedles for Accurate Transdermal Positioning and Ultraminimal-Invasive Biomarker Detection with Mechanical Robustness. Research, 2022.","DOI":"10.34133\/2022\/9869734"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"19446","DOI":"10.1021\/acsami.4c23014","article-title":"Optical Microneedle-Enhanced Transdermal Light Scattering for In Situ Photothermal Therapy Targeting Basal-Layer Psoriasis","volume":"17","author":"Zhao","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Zewail, M., Abbas, H., Sayed, N.E., and Abd-El-Azim, H. (2025). Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management. Eur. J. Pharm. Biopharm., 210.","DOI":"10.1016\/j.ejpb.2025.114692"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/1061186X.2024.2365930","article-title":"Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis","volume":"32","author":"Zewail","year":"2024","journal-title":"J. Drug Target."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.apsb.2025.09.037","article-title":"Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis","volume":"16","author":"Yuan","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2147\/CCID.S313429","article-title":"Current Advances of Nanocarrier Technology-Based Active Cosmetic Ingredients for Beauty Applications","volume":"14","author":"Zhou","year":"2021","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Souto, E.B., Macedo, A.S., Dias-Ferreira, J., Cano, A., Zieli\u0144ska, A., and Matos, C.M. (2021). Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs). Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189743"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Chauhan, M., Chandra, J., Gupta, G., Ramaiah, R., Hani, U., and Kesharwani, P. (2025). Harnessing phytoconstituents in ethosomes: A new frontier in skin disorder management. Int. J. Pharm., 671.","DOI":"10.1016\/j.ijpharm.2025.125273"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.2174\/1381612829666230803111120","article-title":"Current State of Lipid Nanoparticles (SLN and NLC) for Skin Applications","volume":"29","author":"Sinani","year":"2023","journal-title":"Curr. Pharm. Des."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.2174\/1381612826666200614175236","article-title":"Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders","volume":"26","author":"Waghule","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Madan, J.R., Khobaragade, S., Dua, K., and Awasthi, R. (2020). Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast. Dermatol. Ther., 33.","DOI":"10.1111\/dth.13370"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s13346-020-00723-6","article-title":"Nanostructured lipid carrier co-delivering tacrolimus and TNF-\u03b1 siRNA as an innovate approach to psoriasis","volume":"10","author":"Viegas","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.xphs.2021.08.023","article-title":"Resveratrol-Loaded Vesicular Elastic Nanocarriers Gel in Imiquimod-Induced Psoriasis Treatment: In Vitro and In Vivo Evaluation","volume":"111","author":"Elgewelly","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Moussa, A.Y., Abbas, H., Zewail, M., Gaafar, P.M.E., and Ibrahim, N. (2024). Green preparation and evaluation of the anti-psoriatic activity of vesicular elastic nanocarriers of kojic acid from Aspergillus oryzae N12: Repurposing of a dermo-cosmetic lead. Arch. Pharm., 357.","DOI":"10.1002\/ardp.202400410"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1021\/acsptsci.4c00493","article-title":"Eugenol-Loaded Lipid Nanoparticles-Derived Hydrogels Ameliorate Psoriasis-like Skin Lesions by Lowering Oxidative Stress and Modulating Inflammation","volume":"7","author":"Keshari","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.2147\/IJN.S406649","article-title":"Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-\u03b1-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice","volume":"18","author":"Zhao","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1021\/acs.molpharmaceut.3c00729","article-title":"Development of a Deep Eutectic Solvent-Assisted Kaempferol Hydrogel: A Promising Therapeutic Approach for Psoriasis-like Skin Inflammation","volume":"20","author":"Su","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Xu, J., Chen, H., Chu, Z., Li, Z., Chen, B., Sun, J., Lai, W., Ma, Y., He, Y., and Qian, H. (2022). A multifunctional composite hydrogel as an intrinsic and extrinsic coregulator for enhanced therapeutic efficacy for psoriasis. J. Nanobiotechnol., 20.","DOI":"10.1186\/s12951-022-01368-y"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhang, Y., Yang, Z., Zhang, L., Chen, X., Yang, G., Zhan, J., Li, S., He, F., and Fan, G. (2023). Mesoporous silica-based nanocarriers with dual response to pH and ROS for enhanced anti-inflammation therapy of 5-demethylnobiletin against psoriasis-like lesions. Int. J. Pharm., 645.","DOI":"10.1016\/j.ijpharm.2023.123373"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Li, J., Yuan, Z., Shi, S., Chen, X., Yu, S., Qi, X., Deng, T., Zhou, Y., Tang, D., and Xu, S. (2024). Microneedle patches incorporating zinc-doped mesoporous silica nanoparticles loaded with betamethasone dipropionate for psoriasis treatment. J. Nanobiotechnol., 22.","DOI":"10.1186\/s12951-024-02986-4"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Wang, Y., Qin, L., Li, X., Wang, L., Ling, G., and Zhang, P. (2025). Dual-strategy microneedles of bio-oxygen therapy and artificial enzyme anti-oxidation for psoriasis treatment. Int. J. Biol. Macromol., 291.","DOI":"10.1016\/j.ijbiomac.2024.139210"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Mou, Y., Ma, Y., Yu, X., Wang, Y., Wang, S., and Wang, S. (2026). Mitochondria-targeted nanozyme system for psoriasis treatment. J. Nanobiotechnol., 24.","DOI":"10.1186\/s12951-026-04068-z"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Qin, L., Jiao, H., Wang, Y., Yang, L., Shi, X., and Zhang, P. (2025). Celastrol-loaded metal-phenolic nanozymes integrated microneedles with ROS scavenging and anti-inflammatory activities for psoriasis treatment. Asian J. Pharm. Sci., 20.","DOI":"10.1016\/j.ajps.2025.101062"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/acs.biomac.4c01442","article-title":"Antibacterial Chitosan-Based Double-Network Hydrogel Patch Loaded with Antioxidant Ceria Nanoparticles and Betamethasone to Treat Psoriasis","volume":"26","author":"Yeo","year":"2025","journal-title":"Biomacromolecules"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Liu, Y., Tao, S., Zhang, Z., Li, T., Wang, H., Mu, J., Wu, Y., He, Z., Zhang, C., and Lunter, D.J. (2025). Perilla frutescens Leaf-Derived Extracellular Vesicle-Like Particles Carry Pab-miR-396a-5p to Alleviate Psoriasis by Modulating IL-17 Signaling. Research, 8.","DOI":"10.34133\/research.0675"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/acsbiomaterials.5c00760","article-title":"Harnessing Microneedles for Delivery and Preservation of Natural Killer Cell-Derived Extracellular Vesicles","volume":"11","author":"Lim","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.apsb.2025.02.038","article-title":"Microneedle delivery platform integrated with Staphylococcus epidermidis-derived extracellular vesicles-based nanoantibiotics for efficient bacterial infection atopic dermatitis treatment","volume":"15","author":"Zhou","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Vandghanooni, S., Kehtari, P., and Ahdeno, N. (2025). Immune-modulatory biomimetic nanoparticles: Advances in design, mechanisms, and nanomedicine applications. Bioimpacts, 15.","DOI":"10.34172\/bi.33124"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Chen, Z.Q., Tang, T.T., Tang, R.N., Zhang, Y., Zhang, Y.L., Yang, H.B., Song, J., Yang, Q., Qin, S.F., and Chen, F. (2025). A comprehensive evaluation of stability and safety for HEK293F-derived extracellular vesicles as promising drug delivery vehicles. J. Control. Release, 382.","DOI":"10.1016\/j.jconrel.2025.113673"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s13346-020-00809-1","article-title":"Novel nanocrystal-based formulations of apremilast for improved topical delivery","volume":"11","author":"Parmar","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Liu, Y., Gao, J., Cheng, Y., Han, Y., and Zheng, Y. (2026). Tetrandrine nanocrystals development for enhanced transdermal delivery and anti-psoriatic activity on imiquimod-induced psoriasis mouse model. Colloids Surf. B Biointerfaces, 266.","DOI":"10.1016\/j.colsurfb.2026.115848"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Parmar, P.K., Sharma, N., Wasil Kabeer, S., Rohit, A., and Bansal, A.K. (2022). Nanocrystal-based gel of apremilast ameliorates imiquimod-induced psoriasis by suppressing inflammatory responses. Int. J. Pharm., 622.","DOI":"10.1016\/j.ijpharm.2022.121873"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.colsurfb.2018.01.053","article-title":"Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties","volume":"164","author":"Pivetta","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Eltaib, L., Alotaibi, H., Hamod, M.A., Alfuraih, S., Hamood, N.A., Balkhair, A.M., and Aljasser, A.A. (2026). Nanotechnologies for Skin Drug Delivery: Polymeric, Bio-Based, and Hybrid Nanocarriers with Clinical and Translational Perspectives. Pharmaceuticals, 19.","DOI":"10.3390\/ph19071057"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Lee, H.J., and Kim, M. (2023). Challenges and Future Trends in the Treatment of Psoriasis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713313"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Jian, Y., Zheng, Q., Hu, S., and Jian, Y. (2025). siRNA nanodelivery systems in the treatment of skin Diseases: Research progress and clinical translation prospects. Eur. J. Pharmacol., 1005.","DOI":"10.1016\/j.ejphar.2025.178075"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.2174\/1381612824666180807120017","article-title":"Current Non-viral siRNA Delivery Systems as a Promising Treatment of Skin Diseases","volume":"24","author":"Rosa","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.2147\/IJN.S504639","article-title":"Using siRNA-Based Anti-Inflammatory Lipid Nanoparticles for Gene Regulation in Psoriasis","volume":"20","author":"Zeng","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2021.08.039","article-title":"TNF\u03b1 siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy","volume":"338","author":"Suzuki","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2217\/nnm.13.202","article-title":"Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques","volume":"9","author":"Marepally","year":"2014","journal-title":"Nanomedicine"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.05.017","article-title":"Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment","volume":"246","author":"Boakye","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Deng, Y., Chen, J., Zhao, Y., Yan, X., Zhang, L., Choy, K., Hu, J., Sant, H.J., Gale, B.K., and Tang, T. (2016). Transdermal Delivery of siRNA through Microneedle Array. Sci. Rep., 6.","DOI":"10.1038\/srep21422"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jconrel.2022.05.032","article-title":"Laser-assisted nanocarrier delivery to achieve cutaneous siRNA targeting for attenuating psoriasiform dermatitis","volume":"347","author":"Lee","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Zhou, H., Lu, J., Yin, B., Meng, Y., Zhu, C., Wu, X., Liu, J., Zhu, Q., Tai, Z., and Chen, Z. (2026). Transdermal Delivery of PCSK9 siRNA via Biomimetic Nanovesicle-Loaded Microneedles for Psoriasis Immunomodulation. Adv. Healthc. Mater., 15.","DOI":"10.1002\/adhm.202504232"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Hao, L., Yu, P., Yan, R., Li, K., Luo, Z., Xiang, S., Wang, Y., Fang, C., Wang, G., and Ma, S. (2026). Transdermal siRNA delivery via biomineralized nanoparticle-incorporated microneedles modulates cuproptosis-ferroptosis interaction for psoriasis therapy. Mater. Today Bio, 37.","DOI":"10.1016\/j.mtbio.2026.102991"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Domingo, S., Sol\u00e9, C., Molin\u00e9, T., Ferrer, B., and Cort\u00e9s-Hern\u00e1ndez, J. (2020). MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis. Cells, 9.","DOI":"10.3390\/cells9122656"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Yang, S.C., Alalaiwe, A., Lin, Z.C., Lin, Y.C., Aljuffali, I.A., and Fang, J.Y. (2022). Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases. Biomolecules, 12.","DOI":"10.3390\/biom12081072"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1346-8138.15149","article-title":"Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice","volume":"47","author":"Feng","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2017.11.013","article-title":"Towards topical microRNA-directed therapy for epidermal disorders","volume":"269","author":"Ross","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1021\/acs.analchem.1c04401","article-title":"A Sample and Detection Microneedle Patch for Psoriasis MicroRNA Biomarker Analysis in Interstitial Fluid","volume":"94","author":"Qiao","year":"2022","journal-title":"Anal. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"34449","DOI":"10.1021\/jacs.5c08376","article-title":"Strain-Promoted mRNA Transdermal Delivery by Lipoic Lipid Nanoparticles for Therapeutic Skin Genome Editing","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Wan, T., Pan, Q., and Ping, Y. (2021). Microneedle-assisted genome editing: A transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders. Sci. Adv., 7.","DOI":"10.1126\/sciadv.abe2888"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Tan, E., Wan, T., Pan, Q., Duan, J., Zhang, S., Wang, R., Gao, P., Lv, J., Wang, H., and Li, D. (2024). Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders. Sci. Adv., 10.","DOI":"10.1126\/sciadv.adl4336"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Bhat, P., and Garibyan, L. (2022). The Potential of CRISPR-Guided Therapies in the Dermatology Clinic. JID Innov., 2.","DOI":"10.1016\/j.xjidi.2022.100103"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Ghosh, U., and Tay, A. (2026). Biophysical considerations for designing viruses, lipid nanoparticles and virus-like particles for CRISPR-based genome editing. J. Control. Release, 398.","DOI":"10.1016\/j.jconrel.2026.115204"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Xu, G., Ma, G., Sun, J., Yu, X., Sun, J., and Gao, B. (2025). Comprehensive analysis of pyroptosis-related genes in psoriasis and targeted gene editing of CASP1 and CASP5 using lipid nanoparticles to alleviate skin inflammation. Front. Bioeng. Biotechnol., 13.","DOI":"10.3389\/fbioe.2025.1639869"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bsheal.2025.05.003","article-title":"Biosafety considerations triggered by genome-editing technologies","volume":"7","author":"Li","year":"2025","journal-title":"Biosaf. Health"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Hu, H., Ma, Z., Zhang, Z., Chen, Y., Hu, K., Zhang, P., and Liu, J. (2026). Nanotechnology advances for psoriasis treatment and future prospects. Discov. Nano, 21.","DOI":"10.1186\/s11671-026-04569-8"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/j.ymthe.2026.03.010","article-title":"SORT LNPs encapsulating Cas9 mRNA achieve efficient editing in skeletal muscle in a dystrophic mouse model","volume":"34","author":"Iyer","year":"2026","journal-title":"Mol. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.7150\/thno.101845","article-title":"Biomineralized in situ catalytic nanoreactor integrated microneedle patch for on demand immunomodulator supply to combat psoriasis","volume":"14","author":"Li","year":"2024","journal-title":"Theranostics"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Yang, Q., Shi, W., Tian, Y., Liu, Y., Guo, P., Yang, Q., Xiong, S., Tuo, W., Yi, X., and Zhao, J. (2025). Shield microneedles loaded with biphasic-delivery liposomes modulate skin oxidation\/immunity dual-axis for psoriasis therapy. Mater. Today Bio, 35.","DOI":"10.1016\/j.mtbio.2025.102396"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.apsb.2025.12.025","article-title":"Advancing psoriasis therapy through oxygen-boosted dual-section microneedle technology","volume":"16","author":"Albakr","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"28479","DOI":"10.1021\/acsami.6c04691","article-title":"Precision Engineered Dissolving Microneedles Enable Green-Light Activated Chemo-Photodynamic Therapy for Psoriasis","volume":"18","author":"Liu","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Cui, L., Lu, H., Cai, J., Li, Y., Chen, Z., Zhang, Y., Li, B., Wang, Y., Yang, N., and Yao, L. (2026). Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammation. Nat. Commun., 17.","DOI":"10.1038\/s41467-026-77494-0"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Xu, X., Long, C., Zhou, Y., Fei, L., Zhou, Y., and Qi, M. (2026). Innovative Microneedle Patches for Psoriasis Treatment: A Dual Approach With Methotrexate-Zinc and Difelikefalin for Enhanced Therapeutic Outcomes. Small, 22.","DOI":"10.1002\/smll.73958"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/exd.13935","article-title":"The role of the microbiome in scalp hair follicle biology and disease","volume":"29","author":"Rudnicka","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jid.2023.02.023","article-title":"Extracellular Vesicles of Commensal Skin Microbiota Alleviate Cutaneous Inflammation in Atopic Dermatitis Mouse Model by Re-Establishing Skin Homeostasis","volume":"145","author":"Zhou","year":"2025","journal-title":"J. Investig. Dermatol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Ou, Z., Zou, K., Zeng, L., Wang, J., Yang, H., Cao, Y., Wei, S., Li, Y., Zhang, Y., and Wang, H. (2026). Inflammation-triggered nanodrug delivery microneedles targeting pathogenic COX2+ endothelial cell-mediated glycocalyx degradation to ameliorate psoriasis. Biomaterials, 337.","DOI":"10.1016\/j.biomaterials.2026.124516"},{"key":"ref_137","first-page":"83","article-title":"Topical treatment of tyrosine kinase 2 inhibitor through borneol-embedded hydrogel: Evaluation for preventive, therapeutic, and Recurrent management of psoriasis","volume":"41","author":"Lai","year":"2024","journal-title":"Bioact. Mater."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Hagino, T., and Kanda, N. (2026). Systemic Treatment of Psoriasis: Current Evidence on Efficacy and Safety. J. Dermatol., Epub ahead of print.","DOI":"10.1111\/1346-8138.70457"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1021\/acsbiomaterials.5c00826","article-title":"Therapeutic Potential of Rose Hip-Derived Nanoparticles for Psoriatic Skin Inflammation","volume":"11","author":"Hashimoto","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Zhuo, M., Cheng, N., Du, J., Wang, T., Sun, C., Lu, S., Wang, J., and Ding, D. (2025). Selenium-functionalized hyaluronic acid dissolvable microneedle patch synergistic herbal shikonin-loaded tetrahedral framework nucleic acids for psoriasis therapy. Mater. Today Bio, 35.","DOI":"10.1016\/j.mtbio.2025.102413"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Selmin, F., Franz\u00e8, S., Casiraghi, A., and Cilurzo, F. (2022). Spotlight on Calcipotriol\/Betamethasone Fixed-Dose Combination in Topical Formulations: Is There Still Room for Innovation?. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102085"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Moftah, N.H., Elbakry, A.M., Nouh, N.M., and Mohamed, S.H. (2025). Excimer light versus topical methotrexate 1% hydrogel in treatment of scalp psoriasis: Clinical and dermoscopic study. Arch. Dermatol. Res., 317.","DOI":"10.1007\/s00403-024-03676-9"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014A simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_144","first-page":"561","article-title":"Patient-reported outcomes assessment tools for use in psoriasis in Spain: A systematic review","volume":"110","author":"Dilla","year":"2019","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2340\/00015555-2562","article-title":"Patient-reported Outcomes and Clinical Response in Patients with Moderate-to-severe Plaque Psoriasis Treated with Tonsillectomy: A Randomized Controlled Trial","volume":"97","author":"Thorleifsdottir","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-3083.2012.04525.x","article-title":"Adherence to topical treatment in psoriasis: A systematic literature review","volume":"26","author":"Devaux","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Mansoor, I., Eassa, H.A., Mohammed, K.H.A., Abd El-Fattah, M.A., Abdo, M.H., Rashad, E., Eassa, H.A., Saleh, A., Amin, O.M., and Nounou, M.I. (2022). Microneedle-Based Vaccine Delivery: Review of an Emerging Technology. AAPS PharmSciTech, 23.","DOI":"10.1208\/s12249-022-02250-8"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/skinhd\/vzaf010","article-title":"Oral and topical vitamin D treatment strategies in psoriasis","volume":"5","author":"Mai","year":"2025","journal-title":"Ski. Health Dis."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Sun, W., Chen, J., Li, J., She, X., Ma, H., Wang, S., Liu, J., and Yuan, Y. (2023). Vitamin D receptor-deficient keratinocytes-derived exosomal miR-4505 promotes the macrophage polarization towards the M1 phenotype. PeerJ, 11.","DOI":"10.7717\/peerj.15798"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Fucikova, J., Palova-Jelinkova, L., Bartunkova, J., and Spisek, R. (2019). Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02393"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Pietraforte, I., and Frasca, L. (2023). Autoreactive T-Cells in Psoriasis: Are They Spoiled Tregs and Can Therapies Restore Their Functions?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054348"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Arce-Sillas, A., \u00c1lvarez-Luqu\u00edn, D.D., Tamaya-Dom\u00ednguez, B., Gomez-Fuentes, S., Trejo-Garc\u00eda, A., Melo-Salas, M., C\u00e1rdenas, G., Rodr\u00edguez-Ram\u00edrez, J., and Adalid-Peralta, L. (2016). Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation. J. Immunol. Res., 2016.","DOI":"10.1155\/2016\/1720827"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Churlaud, G., Pitoiset, F., Jebbawi, F., Lorenzon, R., Bellier, B., Rosenzwajg, M., and Klatzmann, D. (2015). Human and Mouse CD8+CD25+FOXP3+ Regulatory T Cells at Steady State and during Interleukin-2 Therapy. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00171"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.jid.2018.05.021","article-title":"Proportion of CD4+CD49b+LAG-3+ Type 1 Regulatory T Cells in the Blood of Psoriasis Patients Inversely Correlates with Psoriasis Area and Severity Index","volume":"138","author":"Kim","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Li, Y., An, M., Yao, L., and Lu, J. (2025). iTr35 cells: A novel immunoregulatory subset involved in bone loss in rheumatoid arthritis and clinical implications. Ann. Med., 57.","DOI":"10.1080\/07853890.2025.2565438"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Ortega, M., Romero-L\u00f3pez, N., Casasola-Vargas, J.C., Burgos-Vargas, R., Dom\u00ednguez-L\u00f3pez, M.L., and Romero-L\u00f3pez, J.P. (2025). Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1621396"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Korn, T., and Muschaweckh, A. (2019). Stability and Maintenance of Foxp3+ Treg Cells in Non-lymphoid Microenvironments. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02634"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: A review","volume":"48","author":"Yamanaka","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Ten Bergen, L.L., Petrovic, A., Aarebrot, A.K., and Appel, S. (2020). Current knowledge on autoantigens and autoantibodies in psoriasis. Scand. J. Immunol., 92.","DOI":"10.1111\/sji.12945"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Takahashi, T., and Yamasaki, K. (2020). Psoriasis and Antimicrobial Peptides. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186791"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2022.08.020","article-title":"From vaccines to nanovaccines: A promising strategy to revolutionize rheumatoid arthritis treatment","volume":"350","author":"Zhang","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/acsbiomaterials.5c01072","article-title":"Antigen-Specific Inverse Vaccination Strategies Using Particle Systems for Multiple Sclerosis","volume":"12","author":"Clark","year":"2026","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41565-020-00810-2","article-title":"Inducing immune tolerance with dendritic cell-targeting nanomedicines","volume":"16","author":"Desai","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Moawad, F., Ruel, Y., Rezaei, N., Alsarraf, J., Pichette, A., Legault, J., Pouliot, R., and Brambilla, D. (2024). Microneedles with Implantable Tip-Accumulated Therapeutics for the Long-Term Management of Psoriasis. Small, 20.","DOI":"10.1002\/smll.202405927"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"C\u00e1rcamo-Mart\u00ednez, \u00c1., Mallon, B., Anjani, Q.K., Dom\u00ednguez-Robles, J., Utomo, E., Vora, L.K., Tekko, I.A., Larra\u00f1eta, E., and Donnelly, R.F. (2021). Enhancing intradermal delivery of tofacitinib citrate: Comparison between powder-loaded hollow microneedle arrays and dissolving microneedle arrays. Int. J. Pharm., 593.","DOI":"10.1016\/j.ijpharm.2020.120152"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Xu, Y., Liu, X., and Fang, D. (2026). Regulatory T cells in the skin: Origin, function, and plasticity. JID Innov., 6.","DOI":"10.1016\/j.xjidi.2026.100511"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jconrel.2023.07.023","article-title":"Microneedle-enabled therapeutics delivery and biosensing in clinical trials","volume":"360","author":"Zhang","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"22275","DOI":"10.1021\/acsnano.4c06286","article-title":"Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial System","volume":"18","author":"Zamora","year":"2024","journal-title":"ACS Nano"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Alanazi, J., Aleanizy, F.S., and Alqahtani, F.Y. (2025). Nanotechnology Approaches for Mitigating Biologic Immunogenicity: A Literature Review. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17070888"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jid.2025.09.005","article-title":"Reevaluating the Imiquimod Model: A Barrier to Translational Progress in Psoriasis","volume":"146","author":"Smith","year":"2026","journal-title":"J. Investig. Dermatol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/exd.14551","article-title":"Cytokine induced 3-D organotypic psoriasis skin model demonstrates distinct roles for NF-\u03baB and JAK pathways in disease pathophysiology","volume":"31","author":"McDonald","year":"2022","journal-title":"Exp. Dermatol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.2353\/ajpath.2010.100078","article-title":"Development of a bioengineered skin-humanized mouse model for psoriasis: Dissecting epidermal-lymphocyte interacting pathways","volume":"177","author":"Murillas","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"16","DOI":"10.47102\/annals-acadmedsg.2021380","article-title":"Novel transdermal device for delivery of triamcinolone for nail psoriasis treatment","volume":"51","author":"Yew","year":"2022","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.actbio.2025.04.015","article-title":"Drug-loaded microneedle patches containing regulatory T cell-derived exosomes for psoriasis treatment","volume":"198","author":"Ou","year":"2025","journal-title":"Acta Biomater."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.autrev.2013.09.008","article-title":"Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality?","volume":"13","author":"Lee","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cei.12038","article-title":"Tolerogenic dendritic cell therapy for rheumatoid arthritis: Where are we now?","volume":"172","author":"Hilkens","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri2869","article-title":"The Immune Tolerance Network at 10 years: Tolerance research at the bedside","volume":"10","author":"Bluestone","year":"2010","journal-title":"Nat. Rev. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/784\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:09:28Z","timestamp":1788862168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":178,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090784"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090784","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]}}}